(Total Views: 451)
Posted On: 09/30/2024 9:08:30 PM
Post# of 148863
I’ll admit that I was the hack that brought up CCR5 blockade as a pathway to protecting infants against cancer and hoped for a paper by last Thursday. I had no idea this paper would drop. Literally, I just thought of it after watching a St Jude’s commercial on TV. Cardamibe may have said that I was prescient. But in fact, and apparently, I’m way late to this concept.
FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques
https://www.tandfonline.com/doi/full/10.1080/...24.2406788
My two questions are these. Stupid question, but before being published was this paper peer-reviewed?
Of course it was, and completely new subject matter.
I had 5-6 other papers in peer review that I’ve been awaiting publication.
Second question, how many papers are going to publication soon?
And just for fun 3rd question re: publications…what else is new?
FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques
https://www.tandfonline.com/doi/full/10.1080/...24.2406788
My two questions are these. Stupid question, but before being published was this paper peer-reviewed?
Of course it was, and completely new subject matter.
I had 5-6 other papers in peer review that I’ve been awaiting publication.
Second question, how many papers are going to publication soon?
And just for fun 3rd question re: publications…what else is new?
(3)
(0)Scroll down for more posts ▼
